Table 3. Linear mixed effects model estimates for sprint F-V variables, assessing main effects of device and trial.
Variables Estimate SE t-statistic p ηp2
Tau (s) 0.042 0.015 2.694 0.010 0.129
Amax (m·s-2) -0.176 0.078 -2.259 0.028 0.094
Vmax (m·s-1) 0.083 0.032 2.579 0.013 0.120
V0 (m·s-1) 0.100 0.038 2.625 0.012 0.123
F0 (N·kg-1) -0.195 0.079 -2.465 0.017 0.110
Pmax (W·kg-1) -0.265 0.134 -1.976 0.054 0.074
RFmax (%) -0.898 0.391 -2.294 0.026 0.097
SFV (N·s·m-1·kg-1) 0.030 0.012 2.607 0.012 0.122
T5m (s) 0.011 0.006 1.909 0.062 0.069
T10m (s) 0.011 0.007 1.712 0.093 0.056
T15m (s) 0.011 0.007 1.638 0.108 0.052
T20m (s) 0.005 0.007 0.728 0.470 0.011
A5m (m·s-2) -0.059 0.028 -2.111 0.040 0.083
A10m (m·s-2) -0.026 0.016 -1.638 0.108 0.052
A15m (m·s-2) -0.010 0.010 -0.983 0.330 0.019
A20m (m·s-2) 0.002 0.008 0.272 0.787 0.002
Interaction effects between device and trial were not statistically significant (all p > 0.05) and were removed from the final models.